Table 3 3-Year clinical outcomes
3-Years clinical outcomes | Before PSM | 3-Years clinical outcomes | After PSM | ||||
|---|---|---|---|---|---|---|---|
Non-HCL n = 2222 | HCL n = 210 | P value | Non-HCL n = 172 | HCL n = 172 | P value | ||
TVF | 17 (9.9) | 34 (19.8) | 0.015 | ||||
MACE | 239 (10.8) | 49 (23.3) | < 0.001 | MACE | 23 (13.4) | 37 (21.5) | 0.065 |
All-cause death | 97 (4.4) | 17 (8.1) | 0.023 | All-cause death | 8 (4.7) | 14 (8.1) | 0.271 |
Cardiac death | 51 (2.3) | 12 (5.7) | 0.006 | Cardiac death | 3 (1.7) | 11 (6.4) | 0.056 |
MI | 115 (5.2) | 23 (11.0) | 0.001 | MI | 11 (6.4) | 20 (11.6) | 0.132 |
ARR | 125 (5.6) | 34 (16.2) | < 0.001 | ARR | 12 (7.0) | 25 (14.5) | 0.037 |
T/CVR | 8 (4.7) | 22 (12.8) | 0.013 | ||||
ST | 17 (0.8) | 7 (3.3) | 0.001 | ST | 2 (1.2) | 6 (3.5) | 0.283 |
Bleeding | 35 (1.6) | 4 (1.9) | 0.939 | Bleeding | 2 (1.2) | 3 (1.7) | 1.000 |
Stroke | 22 (1.0) | 2 (1.0) | 1.000 | Stroke | 2 (1.2) | 1 (0.6) | 1.000 |
Follow-up < 3 year | 167 (7.5) | 11 (5.2) | 0.283 | Follow-up < 3 year | 12 (7.0) | 10 (5.8) | 0.826 |